Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: VAREX IMAGING (VREX) Q3 Earnings Expected to Decline

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2020 following the close of regular trading on Wednesday, August 12, 2020. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.

Varex Schedules Third Quarter Fiscal Year 2020 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that effective July 27, 2020, Shubham “Sam” Maheshwari has joined Varex as its Chief Financial Officer (CFO), where he will lead the company’s finance and information technology organizations. “We are excited to have Sam join the Varex team,” said Sunny Sanyal, President and Chief Executive Officer of Varex.

Shubham Maheshwari Joins Varex as Chief Financial Officer

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will showcase its latest X-ray tubes and sources, digital detectors, connect and control devices, and software solutions at the 32nd annual European Congress of Radiology (ECR). The European Society of Radiology’s 2020 congress has transitioned to a virtual exhibition format, which will take place July 15 - 21, 2020. In addition to Varex’s existing X-ray imaging product portfolio, the company will

Varex to Showcase New X-Ray Components at ECR 2020 Virtual Exhibition

VREX vs. SRDX: Which Stock Is the Better Value Option?

Today I’m looking at the other side of medical-adjacent stocks to recommend a bearish position on Varex Imaging Corporation (NASDAQ:VREX).
The post Varex Imaging is in the Bearish Segment of the Medical Sector appeared first on InvestorPlace.

Varex Imaging is in the Bearish Segment of the Medical Sector

Varex (VREX) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Varex (VREX) Surges: Stock Moves 6.2% Higher

Shares swoon after the company announces that it is raising capital.

Why Varex Imaging Stock Is Sinking Today

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q2 2020 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -66.67% and -1.83%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Lags Q2 Earnings and Revenue Estimates

VAREX IMAGING (VREX) Reports Next Week: Wall Street Expects Earnings Growth

VAREX IMAGING (VREX) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q1 2020 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -25.00% and 4.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Q1 Earnings Miss Estimates

VAREX IMAGING (VREX) Earnings Expected to Grow: Should You Buy?

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q4 2019 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 0.00% and -0.38%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Matches Q4 Earnings Estimates

Investors pushed this small-cap stock lower following its third-quarter earnings report.

Why Varex Imaging Stock Lost 17% in August

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q3 2019 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -22.58% and 4.88%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

VAREX IMAGING (VREX) Q3 Earnings Miss Estimates

NuVasive

VREX vs. NUVA: Which Stock Is the Better Value Option?

Varex Imaging Corporation (VREX) CEO Sunny Sanyal on Q2 2019 Results - Earnings Call Transcript

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 3.03% and -0.27%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

News for Varex Imaging Stock (VREX)